ID   NCE-G 28T
AC   CVCL_0V15
SY   NCE G-28T; NCE-G28T; G28T
DR   EFO; EFO_0006407
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471523
DR   EGA; EGAS00001000610
DR   PharmacoDB; G28T_389_2019
DR   Wikidata; Q54907672
RX   PubMed=26589293;
RX   PubMed=3275500;
RX   PubMed=8289093;
RX   PubMed=25485619;
RX   PubMed=25877200;
CC   HLA typing: A*01:01,31:01; B*08:01,13:02; C*06:02,07:01 (PubMed=26589293).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N724 ! NCE-G 28
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 15
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//
RX   PubMed=3275500;
RA   Westphal M., Hansel M., Mueller D., Laas R., Kunzmann R., Rohde E.,
RA   Koenig A., Holzel F., Herrmann H.-D.;
RT   "Biological and karyotypic characterization of a new cell line derived
RT   from human gliosarcoma.";
RL   Cancer Res. 48:731-740(1988).
//
RX   PubMed=8289093; DOI=10.1007/BF01324703;
RA   Hamel W., Westphal M., Shepard H.M.;
RT   "Loss in expression of the retinoblastoma gene product in human
RT   gliomas is associated with advanced disease.";
RL   J. Neurooncol. 16:159-165(1993).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//